These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 15738601

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Effect of prognostic factors on the course of acute lymphoblastic leukemia in children].
    Rokicka-Milewska R, Derulska D, Lewicki Z.
    Pediatr Pol; 1988 Nov; 63(11):703-15. PubMed ID: 3253657
    [No Abstract] [Full Text] [Related]

  • 8. Intensive BFM chemotherapy for childhood ALL: interim analysis of the AIEOP-ALL 91 study. Associazione Italiana Ematologia Oncologia Pediatrica.
    Conter V, Aricò M, Valsecchi MG, Rizzari C, Testi A, Miniero R, Di Tullio MT, Lo Nigro L, Pession A, Rondelli R, Messina C, Santoro N, Mori PG, De Rossi G, Tamaro P, Silvestri D, Biondi A, Basso G, Masera G.
    Haematologica; 1998 Sep; 83(9):791-9. PubMed ID: 9825576
    [Abstract] [Full Text] [Related]

  • 9. [Preliminary evaluation of the treatment of recurrences of acute lymphoblastic leukemia by the BFM (Henze) method].
    Ochocka M, Zelenay E.
    Pediatr Pol; 1988 Nov; 63(11):716-22. PubMed ID: 3253658
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Improvement over time in outcome for children with acute lymphoblastic leukemia in second remission given hematopoietic stem cell transplantation from unrelated donors.
    Locatelli F, Zecca M, Messina C, Rondelli R, Lanino E, Sacchi N, Uderzo C, Fagioli F, Conter V, Bonetti F, Favre C, Porta F, Giorgiani G, Pession A.
    Leukemia; 2002 Nov; 16(11):2228-37. PubMed ID: 12399966
    [Abstract] [Full Text] [Related]

  • 16. High-risk childhood acute lymphoblastic leukemia in first remission treated with novel intensive chemotherapy and allogeneic transplantation.
    Marshall GM, Dalla Pozza L, Sutton R, Ng A, de Groot-Kruseman HA, van der Velden VH, Venn NC, van den Berg H, de Bont ES, Maarten Egeler R, Hoogerbrugge PM, Kaspers GJ, Bierings MB, van der Schoot E, van Dongen J, Law T, Cross S, Mueller H, de Haas V, Haber M, Révész T, Alvaro F, Suppiah R, Norris MD, Pieters R.
    Leukemia; 2013 Jul; 27(7):1497-503. PubMed ID: 23407458
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Acute lymphoblastic leukemia: dental health of children in maintenance therapy.
    Sepet E, Aytepe Z, Ozerkan AG, Yalman N, Guven Y, Anak S, Devecioglu O, Agaoglu L, Gedikoglu G.
    J Clin Pediatr Dent; 1998 Jul; 22(3):257-60. PubMed ID: 9641104
    [Abstract] [Full Text] [Related]

  • 19. [Intravenous immunoglobulin preparations in the adjuvant treatment of acute lymphoblastic leukemia in children].
    Rokicka-Milewska R, Derulska D, Skwarska E.
    Pol Tyg Lek; 1988 Aug 22; 43(34):1085-7. PubMed ID: 3150782
    [No Abstract] [Full Text] [Related]

  • 20. [Recurrences after completion of the treatment of acute lymphoblastic leukemia in children].
    Ochocka M, Matysiak M, Newecka-Samól T, Kulus M, Armata J, Balwierz W, Bogusławska-Jaworska J, Chybicka A, Jackowska T, Jakowicka M.
    Pol Tyg Lek; 1988 Aug 22; 47(16-17):350-3. PubMed ID: 1437752
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.